CHINA PHARMA HOLDINGS, INC. Balance Sheet
CPHI|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
CHINA PHARMA HOLDINGS, INC. had $31M in total assets and $23M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $345.1K | $600.0K | $1.4M | $2.0M | $4.9M | $957.7K | $1.1M | $2.0M | $2.7M | - | - | - | - | $4.1M | $3.7M |
| Accounts Receivable | $241.4K | $232.1K | $504.4K | $421.5K | - | - | - | - | - | - | - | $24.9M | $45.1M | - | $69.7M |
| Inventory | $1.6M | $2.3M | $3.7M | $2.9M | $3.3M | $3.7M | $3.6M | $5.1M | $6.4M | $7.3M | $9.7M | $15.3M | $24.7M | $36.4M | $30.4M |
| Current Assets | $2.3M | $3.3M | $6.0M | $6.0M | $9.1M | $5.3M | $5.6M | $8.7M | $12.3M | $17.5M | $25.0M | $43.5M | $84.0M | $112.5M | $110.6M |
| PP&E (Net) | $4.4M | $4.9M | $7.1M | $10.0M | $13.3M | $15.6M | $16.3M | $19.3M | $23.5M | $25.0M | $29.4M | $33.9M | $30.2M | $9.0M | $6.3M |
| Total Assets | $31.0M | $14.9M | $16.5M | $17.8M | $22.6M | $21.1M | $22.2M | $45.4M | $60.0M | $78.5M | $97.2M | $121.1M | $157.6M | $163.2M | $156.4M |
| Current Liabilities | $7.4M | $5.0M | $6.8M | $12.7M | $10.5M | $11.4M | $10.0M | $10.1M | $9.2M | $10.4M | $12.8M | $14.2M | $12.0M | $14.6M | $13.8M |
| Shareholders' Equity | $22.7M | $7.5M | $7.5M | $4.3M | $8.0M | $9.2M | $30.2M | $43.1M | $58.9M | $72.6M | $72.6M | $92.7M | $132.9M | $148.5M | $142.5M |